Maintenance Rituximab Linked to Improved Outcomes in MCL
Talal Hilal, MB, BCh, discusses the findings of a meta-analysis of rituximab maintenance for patients with mantle cell lymphoma (MCL), and the approach to maintenance therapy in patients with MCL.
Source: OncLive